Drug Shortage Report for CARBOPLATIN INJECTION BP
Report ID | 201480 |
Drug Identification Number | 02126680 |
Brand name | CARBOPLATIN INJECTION BP |
Common or Proper name | CARBOPLATIN |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | CARBOPLATIN |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 x 1 vial |
ATC code | L01XA |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-08-25 |
Estimated end date | |
Actual end date | 2023-10-18 |
Shortage status | Resolved |
Updated date | 2023-10-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2023-10-19 | French | Compare |
v11 | 2023-10-19 | English | Compare |
v10 | 2023-09-20 | French | Compare |
v9 | 2023-09-20 | English | Compare |
v8 | 2023-08-31 | French | Compare |
v7 | 2023-08-31 | English | Compare |
v6 | 2023-08-26 | English | Compare |
v5 | 2023-08-21 | French | Compare |
v4 | 2023-08-21 | English | Compare |
v3 | 2023-08-19 | English | Compare |
v2 | 2023-08-09 | French | Compare |
v1 | 2023-08-09 | English | Compare |
Showing 1 to 12 of 12